Access cutting-edge open posterior thoracolumbar spinal fusion procedure treatment through this early phase 1 clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Chicago location
Preparing your pre-screening questions…
Access open posterior thoracolumbar spinal fusion procedure specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related open posterior thoracolumbar spinal fusion procedure treatment provided free
Check if you qualify for this open posterior thoracolumbar spinal fusion procedure clinical trial in Chicago, IL
No-Cost Study Care
Local to Chicago
Convenient for IL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
As tranexamic acid (TXA) becomes more prevalent, all patients are receiving the same dose and method of delivery regardless of their pre-operative risk of transfusion. Therefore, the aim of the study is to determine whether or not repeated dosing of oral or different method of delivery like intravenous (IV) TXA reduces the postoperative reduction in hemoglobin, hematocrit, number of transfusions, and postoperative blood loss following open spine surgery. The regimen that utilizes multiple doses of oral TXA will significantly minimize post-operative blood loss and transfusion requirements compared to the use of a single dose regimen. Furthermore, oral TXA will be as efficacious as intravenous delivery of TXA.
Sponsor: Rush University Medical Center
Yes, this clinical trial (NCT03849443) has an active research site in Chicago, IL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for open posterior thoracolumbar spinal fusion procedure treatment options in Chicago, IL, this clinical trial (NCT03849443) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this early phase 1 clinical trial. You'll receive care from experienced open posterior thoracolumbar spinal fusion procedure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all open posterior thoracolumbar spinal fusion procedure clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Chicago — not just this study.
Browse Pulmonary Embolism Trials in Chicago →